View in EDS

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.
Authors: Yee D; Masonic Cancer Center, University of Minnesota, Minneapolis., DeMichele AM; Perelman School of Medicine, University of Pennsylvania, Philadelphia., Yau C; Department of Surgery, University of California, San Francisco., Isaacs C; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC., Symmans WF; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston., Albain KS; Loyola University Chicago Stritch School of Medicine, Chicago, Illinois., Chen YY; Department of Pathology, University of California, San Francisco., Krings G; Department of Pathology, University of California, San Francisco., Wei S; Department of Pathology, University of Alabama Birmingham., Harada S; Department of Pathology, University of Alabama Birmingham., Datnow B; Department of Pathology, University of California, San Diego., Fadare O; Department of Pathology, University of California, San Diego., Klein M; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis., Pambuccian S; Department of Pathology, Loyola University Chicago Stritch School of Medicine, Chicago, Illinois., Chen B; Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota., Adamson K; Department of Pathology, Swedish Cancer Institute, Seattle, Washington., Sams S; Department of Pathology, University of Colorado, Denver., Mhawech-Fauceglia P; Keck School of Medicine, University of Southern California, Los Angeles., Magliocco A; Department of Pathology, Moffitt Cancer Center, Tampa, Florida., Feldman M; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia., Rendi M; Department of Anatomic Pathology, University of Washington, Seattle., Sattar H; Department of Pathology, University of Chicago, Chicago, Illinois., Zeck J; Department of Pathology, Georgetown University, Washington, DC., Ocal IT; Laboratory Medicine and Pathology, Mayo Clinic Scottsdale, Scottsdale, Arizona., Tawfik O; Department of Pathology and Laboratory Medicine, University of Kansas, Lawrence., LeBeau LG; Department of Pathology, University of Arizona, Tucson., Sahoo S; Department of Pathology, University of Texas Southwestern, Dallas., Vinh T; Inova Pathology Institute, Inova Health System, Falls Church, Virginia., Chien AJ; Division of Hematology and Oncology, University of California, San Francisco., Forero-Torres A; Division of Hematology and Oncology, University of Alabama Birmingham., Stringer-Reasor E; Division of Hematology and Oncology, University of Alabama Birmingham., Wallace AM; Department of Surgery, University of California, San Diego., Pusztai L; Medical Oncology, Yale Cancer Center, New Haven, Connecticut., Boughey JC; Department of Surgery, Mayo Clinic Rochester, Rochester, Minnesota., Ellis ED; Medical Oncology, Swedish Cancer Institute, Seattle, Washington., Elias AD; Department of Medicine, University of Colorado, Denver., Lu J; Medical Oncology, Keck School of Medicine, University of Southern California, Los Angeles., Lang JE; Surgery, Keck School of Medicine, University of Southern California, Los Angeles., Han HS; Medical Oncology, Moffitt Cancer Center, Tampa, Florida., Clark AS; Perelman School of Medicine, University of Pennsylvania, Philadelphia., Nanda R; Hematology and Oncology, University of Chicago Medical Center, Chicago, Illinois., Northfelt DW; Medical Oncology, Mayo Clinic Scottsdale, Scottsdale, Arizona., Khan QJ; Medical Oncology, University of Kansas Medical Center, Lawrence., Viscusi RK; Hematology/Oncology, University of Arizona, Tucson., Euhus DM; Department of Surgery, Johns Hopkins Medicine, Baltimore, Maryland., Edmiston KK; Inova Schar Cancer Institute, Fairfax, Virginia., Chui SY; Genentech, South San Francisco, California., Kemmer K; Knight Cancer Institute, Oregon Health & Science University, Portland., Park JW; Division of Hematology and Oncology, University of California, San Francisco., Liu MC; Department of Oncology, Mayo Clinic Rochester, Rochester, Minnesota., Olopade O; Hematology and Oncology, University of Chicago Medical Center, Chicago, Illinois., Leyland-Jones B; Avera Cancer Institute, Sioux Falls, South Dakota., Tripathy D; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Moulder SL; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Rugo HS; Division of Hematology and Oncology, University of California, San Francisco., Schwab R; Medical Oncology, University of California, San Diego., Lo S; Medical Oncology, Loyola University Chicago Stritch School of Medicine, Chicago, Illinois., Helsten T; Medical Oncology, University of California, San Diego., Beckwith H; Masonic Cancer Center, University of Minnesota, Minneapolis., Haugen P; National Breast Cancer Coalition, Washington, DC., Hylton NM; Department of Radiology and Biomedical Imaging, University of California, San Francisco., Van't Veer LJ; Department of Laboratory Medicine, University of California, San Francisco., Perlmutter J; Gemini Group, Ann Arbor, Michigan., Melisko ME; Division of Hematology and Oncology, University of California, San Francisco., Wilson A; Quantum Leap Healthcare Collaborative, San Francisco, California., Peterson G; Department of Surgery, University of California, San Francisco., Asare AL; Quantum Leap Healthcare Collaborative, San Francisco, California., Buxton MB; Berry Consultants, LLC, Austin, Texas., Paoloni M; Berry Consultants, LLC, Austin, Texas., Clennell JL; Berry Consultants, LLC, Austin, Texas., Hirst GL; Department of Surgery, University of California, San Francisco., Singhrao R; Department of Surgery, University of California, San Francisco., Steeg K; Department of Surgery, University of California, San Francisco., Matthews JB; Department of Surgery, University of California, San Francisco., Asare SM; Quantum Leap Healthcare Collaborative, San Francisco, California., Sanil A; Berry Consultants, LLC, Austin, Texas., Berry SM; Berry Consultants, LLC, Austin, Texas., Esserman LJ; Department of Surgery, University of California, San Francisco., Berry DA; Berry Consultants, LLC, Austin, Texas.
Corporate Authors: I-SPY2 Trial Consortium
Source: JAMA oncology [JAMA Oncol] 2020 Sep 01; Vol. 6 (9), pp. 1355-1362.
Publication Type: Journal Article; Randomized Controlled Trial; Adaptive Clinical Trial
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32701140
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yee+D%22">Yee D</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis.<br /><searchLink fieldCode="AU" term="%22DeMichele+AM%22">DeMichele AM</searchLink>; Perelman School of Medicine, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Yau+C%22">Yau C</searchLink>; Department of Surgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Isaacs+C%22">Isaacs C</searchLink>; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Symmans+WF%22">Symmans WF</searchLink>; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Albain+KS%22">Albain KS</searchLink>; Loyola University Chicago Stritch School of Medicine, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Chen+YY%22">Chen YY</searchLink>; Department of Pathology, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Krings+G%22">Krings G</searchLink>; Department of Pathology, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Wei+S%22">Wei S</searchLink>; Department of Pathology, University of Alabama Birmingham.<br /><searchLink fieldCode="AU" term="%22Harada+S%22">Harada S</searchLink>; Department of Pathology, University of Alabama Birmingham.<br /><searchLink fieldCode="AU" term="%22Datnow+B%22">Datnow B</searchLink>; Department of Pathology, University of California, San Diego.<br /><searchLink fieldCode="AU" term="%22Fadare+O%22">Fadare O</searchLink>; Department of Pathology, University of California, San Diego.<br /><searchLink fieldCode="AU" term="%22Klein+M%22">Klein M</searchLink>; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis.<br /><searchLink fieldCode="AU" term="%22Pambuccian+S%22">Pambuccian S</searchLink>; Department of Pathology, Loyola University Chicago Stritch School of Medicine, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Chen+B%22">Chen B</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Adamson+K%22">Adamson K</searchLink>; Department of Pathology, Swedish Cancer Institute, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Sams+S%22">Sams S</searchLink>; Department of Pathology, University of Colorado, Denver.<br /><searchLink fieldCode="AU" term="%22Mhawech-Fauceglia+P%22">Mhawech-Fauceglia P</searchLink>; Keck School of Medicine, University of Southern California, Los Angeles.<br /><searchLink fieldCode="AU" term="%22Magliocco+A%22">Magliocco A</searchLink>; Department of Pathology, Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Feldman+M%22">Feldman M</searchLink>; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Rendi+M%22">Rendi M</searchLink>; Department of Anatomic Pathology, University of Washington, Seattle.<br /><searchLink fieldCode="AU" term="%22Sattar+H%22">Sattar H</searchLink>; Department of Pathology, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Zeck+J%22">Zeck J</searchLink>; Department of Pathology, Georgetown University, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Ocal+IT%22">Ocal IT</searchLink>; Laboratory Medicine and Pathology, Mayo Clinic Scottsdale, Scottsdale, Arizona.<br /><searchLink fieldCode="AU" term="%22Tawfik+O%22">Tawfik O</searchLink>; Department of Pathology and Laboratory Medicine, University of Kansas, Lawrence.<br /><searchLink fieldCode="AU" term="%22LeBeau+LG%22">LeBeau LG</searchLink>; Department of Pathology, University of Arizona, Tucson.<br /><searchLink fieldCode="AU" term="%22Sahoo+S%22">Sahoo S</searchLink>; Department of Pathology, University of Texas Southwestern, Dallas.<br /><searchLink fieldCode="AU" term="%22Vinh+T%22">Vinh T</searchLink>; Inova Pathology Institute, Inova Health System, Falls Church, Virginia.<br /><searchLink fieldCode="AU" term="%22Chien+AJ%22">Chien AJ</searchLink>; Division of Hematology and Oncology, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Forero-Torres+A%22">Forero-Torres A</searchLink>; Division of Hematology and Oncology, University of Alabama Birmingham.<br /><searchLink fieldCode="AU" term="%22Stringer-Reasor+E%22">Stringer-Reasor E</searchLink>; Division of Hematology and Oncology, University of Alabama Birmingham.<br /><searchLink fieldCode="AU" term="%22Wallace+AM%22">Wallace AM</searchLink>; Department of Surgery, University of California, San Diego.<br /><searchLink fieldCode="AU" term="%22Pusztai+L%22">Pusztai L</searchLink>; Medical Oncology, Yale Cancer Center, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Boughey+JC%22">Boughey JC</searchLink>; Department of Surgery, Mayo Clinic Rochester, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Ellis+ED%22">Ellis ED</searchLink>; Medical Oncology, Swedish Cancer Institute, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Elias+AD%22">Elias AD</searchLink>; Department of Medicine, University of Colorado, Denver.<br /><searchLink fieldCode="AU" term="%22Lu+J%22">Lu J</searchLink>; Medical Oncology, Keck School of Medicine, University of Southern California, Los Angeles.<br /><searchLink fieldCode="AU" term="%22Lang+JE%22">Lang JE</searchLink>; Surgery, Keck School of Medicine, University of Southern California, Los Angeles.<br /><searchLink fieldCode="AU" term="%22Han+HS%22">Han HS</searchLink>; Medical Oncology, Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Clark+AS%22">Clark AS</searchLink>; Perelman School of Medicine, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Nanda+R%22">Nanda R</searchLink>; Hematology and Oncology, University of Chicago Medical Center, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Northfelt+DW%22">Northfelt DW</searchLink>; Medical Oncology, Mayo Clinic Scottsdale, Scottsdale, Arizona.<br /><searchLink fieldCode="AU" term="%22Khan+QJ%22">Khan QJ</searchLink>; Medical Oncology, University of Kansas Medical Center, Lawrence.<br /><searchLink fieldCode="AU" term="%22Viscusi+RK%22">Viscusi RK</searchLink>; Hematology/Oncology, University of Arizona, Tucson.<br /><searchLink fieldCode="AU" term="%22Euhus+DM%22">Euhus DM</searchLink>; Department of Surgery, Johns Hopkins Medicine, Baltimore, Maryland.<br /><searchLink fieldCode="AU" term="%22Edmiston+KK%22">Edmiston KK</searchLink>; Inova Schar Cancer Institute, Fairfax, Virginia.<br /><searchLink fieldCode="AU" term="%22Chui+SY%22">Chui SY</searchLink>; Genentech, South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Kemmer+K%22">Kemmer K</searchLink>; Knight Cancer Institute, Oregon Health & Science University, Portland.<br /><searchLink fieldCode="AU" term="%22Park+JW%22">Park JW</searchLink>; Division of Hematology and Oncology, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Liu+MC%22">Liu MC</searchLink>; Department of Oncology, Mayo Clinic Rochester, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Olopade+O%22">Olopade O</searchLink>; Hematology and Oncology, University of Chicago Medical Center, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Leyland-Jones+B%22">Leyland-Jones B</searchLink>; Avera Cancer Institute, Sioux Falls, South Dakota.<br /><searchLink fieldCode="AU" term="%22Tripathy+D%22">Tripathy D</searchLink>; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Moulder+SL%22">Moulder SL</searchLink>; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; Division of Hematology and Oncology, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Schwab+R%22">Schwab R</searchLink>; Medical Oncology, University of California, San Diego.<br /><searchLink fieldCode="AU" term="%22Lo+S%22">Lo S</searchLink>; Medical Oncology, Loyola University Chicago Stritch School of Medicine, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Helsten+T%22">Helsten T</searchLink>; Medical Oncology, University of California, San Diego.<br /><searchLink fieldCode="AU" term="%22Beckwith+H%22">Beckwith H</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis.<br /><searchLink fieldCode="AU" term="%22Haugen+P%22">Haugen P</searchLink>; National Breast Cancer Coalition, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Hylton+NM%22">Hylton NM</searchLink>; Department of Radiology and Biomedical Imaging, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Van't+Veer+LJ%22">Van't Veer LJ</searchLink>; Department of Laboratory Medicine, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Perlmutter+J%22">Perlmutter J</searchLink>; Gemini Group, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Melisko+ME%22">Melisko ME</searchLink>; Division of Hematology and Oncology, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Wilson+A%22">Wilson A</searchLink>; Quantum Leap Healthcare Collaborative, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Peterson+G%22">Peterson G</searchLink>; Department of Surgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Asare+AL%22">Asare AL</searchLink>; Quantum Leap Healthcare Collaborative, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Buxton+MB%22">Buxton MB</searchLink>; Berry Consultants, LLC, Austin, Texas.<br /><searchLink fieldCode="AU" term="%22Paoloni+M%22">Paoloni M</searchLink>; Berry Consultants, LLC, Austin, Texas.<br /><searchLink fieldCode="AU" term="%22Clennell+JL%22">Clennell JL</searchLink>; Berry Consultants, LLC, Austin, Texas.<br /><searchLink fieldCode="AU" term="%22Hirst+GL%22">Hirst GL</searchLink>; Department of Surgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Singhrao+R%22">Singhrao R</searchLink>; Department of Surgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Steeg+K%22">Steeg K</searchLink>; Department of Surgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Matthews+JB%22">Matthews JB</searchLink>; Department of Surgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Asare+SM%22">Asare SM</searchLink>; Quantum Leap Healthcare Collaborative, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Sanil+A%22">Sanil A</searchLink>; Berry Consultants, LLC, Austin, Texas.<br /><searchLink fieldCode="AU" term="%22Berry+SM%22">Berry SM</searchLink>; Berry Consultants, LLC, Austin, Texas.<br /><searchLink fieldCode="AU" term="%22Esserman+LJ%22">Esserman LJ</searchLink>; Department of Surgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Berry+DA%22">Berry DA</searchLink>; Berry Consultants, LLC, Austin, Texas.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22I-SPY2+Trial+Consortium%22">I-SPY2 Trial Consortium</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101652861%22">JAMA oncology</searchLink> [JAMA Oncol] 2020 Sep 01; Vol. 6 (9), pp. 1355-1362.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Adaptive Clinical Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101652861 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-2445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223742437%22">23742437 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32701140
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamaoncol.2020.2535
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1355
    Titles:
      – TitleFull: Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yee D
      – PersonEntity:
          Name:
            NameFull: DeMichele AM
      – PersonEntity:
          Name:
            NameFull: Yau C
      – PersonEntity:
          Name:
            NameFull: Isaacs C
      – PersonEntity:
          Name:
            NameFull: Symmans WF
      – PersonEntity:
          Name:
            NameFull: Albain KS
      – PersonEntity:
          Name:
            NameFull: Chen YY
      – PersonEntity:
          Name:
            NameFull: Krings G
      – PersonEntity:
          Name:
            NameFull: Wei S
      – PersonEntity:
          Name:
            NameFull: Harada S
      – PersonEntity:
          Name:
            NameFull: Datnow B
      – PersonEntity:
          Name:
            NameFull: Fadare O
      – PersonEntity:
          Name:
            NameFull: Klein M
      – PersonEntity:
          Name:
            NameFull: Pambuccian S
      – PersonEntity:
          Name:
            NameFull: Chen B
      – PersonEntity:
          Name:
            NameFull: Adamson K
      – PersonEntity:
          Name:
            NameFull: Sams S
      – PersonEntity:
          Name:
            NameFull: Mhawech-Fauceglia P
      – PersonEntity:
          Name:
            NameFull: Magliocco A
      – PersonEntity:
          Name:
            NameFull: Feldman M
      – PersonEntity:
          Name:
            NameFull: Rendi M
      – PersonEntity:
          Name:
            NameFull: Sattar H
      – PersonEntity:
          Name:
            NameFull: Zeck J
      – PersonEntity:
          Name:
            NameFull: Ocal IT
      – PersonEntity:
          Name:
            NameFull: Tawfik O
      – PersonEntity:
          Name:
            NameFull: LeBeau LG
      – PersonEntity:
          Name:
            NameFull: Sahoo S
      – PersonEntity:
          Name:
            NameFull: Vinh T
      – PersonEntity:
          Name:
            NameFull: Chien AJ
      – PersonEntity:
          Name:
            NameFull: Forero-Torres A
      – PersonEntity:
          Name:
            NameFull: Stringer-Reasor E
      – PersonEntity:
          Name:
            NameFull: Wallace AM
      – PersonEntity:
          Name:
            NameFull: Pusztai L
      – PersonEntity:
          Name:
            NameFull: Boughey JC
      – PersonEntity:
          Name:
            NameFull: Ellis ED
      – PersonEntity:
          Name:
            NameFull: Elias AD
      – PersonEntity:
          Name:
            NameFull: Lu J
      – PersonEntity:
          Name:
            NameFull: Lang JE
      – PersonEntity:
          Name:
            NameFull: Han HS
      – PersonEntity:
          Name:
            NameFull: Clark AS
      – PersonEntity:
          Name:
            NameFull: Nanda R
      – PersonEntity:
          Name:
            NameFull: Northfelt DW
      – PersonEntity:
          Name:
            NameFull: Khan QJ
      – PersonEntity:
          Name:
            NameFull: Viscusi RK
      – PersonEntity:
          Name:
            NameFull: Euhus DM
      – PersonEntity:
          Name:
            NameFull: Edmiston KK
      – PersonEntity:
          Name:
            NameFull: Chui SY
      – PersonEntity:
          Name:
            NameFull: Kemmer K
      – PersonEntity:
          Name:
            NameFull: Park JW
      – PersonEntity:
          Name:
            NameFull: Liu MC
      – PersonEntity:
          Name:
            NameFull: Olopade O
      – PersonEntity:
          Name:
            NameFull: Leyland-Jones B
      – PersonEntity:
          Name:
            NameFull: Tripathy D
      – PersonEntity:
          Name:
            NameFull: Moulder SL
      – PersonEntity:
          Name:
            NameFull: Rugo HS
      – PersonEntity:
          Name:
            NameFull: Schwab R
      – PersonEntity:
          Name:
            NameFull: Lo S
      – PersonEntity:
          Name:
            NameFull: Helsten T
      – PersonEntity:
          Name:
            NameFull: Beckwith H
      – PersonEntity:
          Name:
            NameFull: Haugen P
      – PersonEntity:
          Name:
            NameFull: Hylton NM
      – PersonEntity:
          Name:
            NameFull: Van't Veer LJ
      – PersonEntity:
          Name:
            NameFull: Perlmutter J
      – PersonEntity:
          Name:
            NameFull: Melisko ME
      – PersonEntity:
          Name:
            NameFull: Wilson A
      – PersonEntity:
          Name:
            NameFull: Peterson G
      – PersonEntity:
          Name:
            NameFull: Asare AL
      – PersonEntity:
          Name:
            NameFull: Buxton MB
      – PersonEntity:
          Name:
            NameFull: Paoloni M
      – PersonEntity:
          Name:
            NameFull: Clennell JL
      – PersonEntity:
          Name:
            NameFull: Hirst GL
      – PersonEntity:
          Name:
            NameFull: Singhrao R
      – PersonEntity:
          Name:
            NameFull: Steeg K
      – PersonEntity:
          Name:
            NameFull: Matthews JB
      – PersonEntity:
          Name:
            NameFull: Asare SM
      – PersonEntity:
          Name:
            NameFull: Sanil A
      – PersonEntity:
          Name:
            NameFull: Berry SM
      – PersonEntity:
          Name:
            NameFull: Esserman LJ
      – PersonEntity:
          Name:
            NameFull: Berry DA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2020 Sep 01
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2374-2445
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: JAMA oncology
              Type: main
ResultId 1